These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging. Reid BG; Stratton MS; Bowers S; Cavasin MA; Demos-Davies KM; Susano I; McKinsey TA J Mol Cell Cardiol; 2016 Aug; 97():106-13. PubMed ID: 27130278 [TBL] [Abstract][Full Text] [Related]
3. The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy. Li Z; Guo Z; Lan R; Cai S; Lin Z; Li J; Wang J; Li Z; Liu P Acta Pharm Sin B; 2021 May; 11(5):1286-1299. PubMed ID: 34094834 [TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650 [TBL] [Abstract][Full Text] [Related]
6. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation. Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188 [TBL] [Abstract][Full Text] [Related]
7. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Duan Q; McMahon S; Anand P; Shah H; Thomas S; Salunga HT; Huang Y; Zhang R; Sahadevan A; Lemieux ME; Brown JD; Srivastava D; Bradner JE; McKinsey TA; Haldar SM Sci Transl Med; 2017 May; 9(390):. PubMed ID: 28515341 [TBL] [Abstract][Full Text] [Related]
8. Function of BRD4 in the pathogenesis of high glucose‑induced cardiac hypertrophy. Wang Q; Sun Y; Li T; Liu L; Zhao Y; Li L; Zhang L; Meng Y Mol Med Rep; 2019 Jan; 19(1):499-507. PubMed ID: 30483785 [TBL] [Abstract][Full Text] [Related]
9. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146 [TBL] [Abstract][Full Text] [Related]
10. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy. Antolic A; Wakimoto H; Jiao Z; Gorham JM; DePalma SR; Lemieux ME; Conner DA; Lee DY; Qi J; Seidman JG; Bradner JE; Brown JD; Haldar SM; Seidman CE; Burke MA JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32603312 [TBL] [Abstract][Full Text] [Related]
11. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries. Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791 [TBL] [Abstract][Full Text] [Related]
12. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states. Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437 [TBL] [Abstract][Full Text] [Related]
13. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload. Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic Reader Bromodomain Containing Protein 2 Facilitates Pathological Cardiac Hypertrophy Lin Z; Li Z; Guo Z; Cao Y; Li J; Liu P; Li Z Front Pharmacol; 2022; 13():887991. PubMed ID: 35694272 [TBL] [Abstract][Full Text] [Related]
15. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression. Gao Z; Yuan T; Zhou X; Ni P; Sun G; Li P; Cheng Z; Wang X Cancer Biol Ther; 2018 May; 19(5):407-415. PubMed ID: 29333921 [TBL] [Abstract][Full Text] [Related]
16. Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice. Lee DU; Katavolos P; Palanisamy G; Katewa A; Sioson C; Corpuz J; Pang J; DeMent K; Choo E; Ghilardi N; Diaz D; Danilenko DM Toxicol Appl Pharmacol; 2016 Jun; 300():47-54. PubMed ID: 27078884 [TBL] [Abstract][Full Text] [Related]
17. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027 [TBL] [Abstract][Full Text] [Related]
18. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation. Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348 [TBL] [Abstract][Full Text] [Related]